StockNews.AI
IDXX
StockNews.AI
215 days

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

1. IDEXX scheduled Q4 2024 earnings release for February 3, 2025. 2. Analyst conference call to follow immediately after earnings release. 3. IDEXX is a leader in pet healthcare innovation. 4. The company delivers crucial diagnostic products globally. 5. IDEXX supports the veterinary community and public health.

3m saved
Insight
Article

FAQ

Why Neutral?

Earnings announcements typically have neutral effects unless results vary significantly from expectations. Past earnings releases have shown mixed reactions based on performance metrics.

How important is it?

Earnings releases are significant for IDXX, affecting investor sentiment and stock valuation.

Why Short Term?

Immediate impacts are likely seen around the earnings release date. Long-term implications depend on the performance post-reporting.

Related Companies

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2024 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year. The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-289-0462 or 1-323-794-2442 and reference passcode 803218. About IDEXX Laboratories IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.

Related News